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Abstract
Background: Clostridium difficile infection (CDI) is understudied in limited resource settings. In addition, provider
awareness of CDI as a prevalent threat is unknown. An assessment of current facilitators and barriers to CDI
identification, management, and prevention is needed in limited resource settings to design and evaluate quality
improvement strategies to effectively minimize the risk of CDI.
Methods: Our study aimed to identify CDI perceptions and practices among healthcare providers in South African
secondary hospitals to identify facilitators and barriers to providing quality CDI care. Qualitative interviews (11
physicians, 11 nurses, 4 pharmacists,) and two focus groups (7 nurses, 3 pharmacists) were conducted at three district
level hospitals in the Cape Town Metropole. Semi-structured interviews elicited provider perceived facilitators, barriers,
and opportunities to improve clinical workflow from patient presentation through CDI (1) Identification, (2) Diagnosis,
(3) Treatment, and (4) Prevention. In addition, a summary provider CDI knowledge score was calculated for each
interviewee for seven components of CDI and management.
Results: Major barriers identified were knowledge gaps in characteristics of C. difficile identification, diagnosis, treatment,
and prevention. The median overall CDI knowledge score (scale 0–7) from individual interviews was 3 [interquartile
range 0.25, 4.75]. Delays in C. difficile testing workflow were identified. Participants perceived supplies for CDI
management and prevention were usually available; however, hand hygiene and use of contact precautions was
inconsistent.
Conclusions: Our analysis provides a detailed description of the facilitators and barriers to CDI workflow and can be
utilized to design quality improvement interventions among limited resource settings.
Keywords: Healthcare associated infection, Infection control, Qualitative study, Antimicrobial stewardship, Global health
Background
Clostridium difficile infection (CDI) is an increasingly
important healthcare-associated infection associated
with long hospitalisations and high patient morbidity
and mortality [1]. CDI often results from normal gut
bacterial disruption due to broad-spectrum antimicrobial
use, allowing for overgrowth of toxigenic C. difficile.
CDI outbreaks have been reported extensively in the
United States (US) and Europe over the last two de-
cades. CDI in these hospitals is prevalent supporting ex-
tensive CDI prevention and control measures. However,
CDI is understudied in low and limited resource set-
tings, including nearly all African countries. Where lim-
ited data exists, a study at a tertiary hospital in Cape
Town, South Africa found 22% of stool samples from
patients with suspected CDI diarrhoea were C. difficile
positive [2]. In addition, patients in South Africa are dis-
proportionately affected by HIV and tuberculosis (TB)
and therefore also experience known CDI risk factors of
prior hospital and antibiotic exposure—exposures that
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can uniquely contribute to an increased risk of CDI and
poor outcomes [3, 4].
Treatment of CDI requires a comprehensive ap-
proach that includes infection prevention and control
(IPC) measures to limit transmission and prevent out-
breaks. Although no CDI IPC guidelines exist specific
to African countries, the Infectious Diseases Society of
America (IDSA) and European Society of Clinical
Microbiology and Infectious Diseases guidelines con-
sistently recommend IPC components of antimicrobial
stewardship programs (ASP) which include effective en-
vironment cleaning, patient isolation, use of personal
protective equipment such as gowns and gloves, sur-
veillance, and education [5]. These evidence-based rec-
ommendations are key to effective CDI management.
The feasibility of using these recommendations in pop-
ulations with limited healthcare resources has not been
established. In addition, healthcare provider knowledge
of CDI and the guidance to effectively mitigate and
manage patient populations at higher risk for CDI is
unknown.
Provider knowledge of CDI and treatment measures
are essential to both successfully manage CDI and
prevent disease transmission. An assessment of current
facilitators and barriers to CDI identification, manage-
ment, and prevention is needed to design and evaluate
improvement strategies to effectively minimize the risk
of CDI. To our knowledge, no comprehensive study of
barriers and facilitators to CDI workflow (identification,
diagnosis, treatment, and prevention) in Sub-Saharan
Africa exists. Our study aims to fill this gap by eliciting
CDI perceptions and management practices among
healthcare providers in South African secondary hospi-
tals to uncover facilitators and barriers to providing
quality CDI care.
Methods
Data collection
We utilized a qualitative approach to elicit health care
providers’ perceptions of barriers and facilitators to
CDI management because it provides detailed process
oriented results. We conducted semi-structured inter-
views and focus groups among clinical providers at
three secondary hospitals in South Africa. A Systems
Engineering Initiative for Patient Safety (SEIPS) model
served as a framework for the interview guide. The
SEIPS framework connects work systems to patient and
organizational outcomes, while including interactions
in the work system between available tools, people,
tasks, the internal environment, and the organization
[6]. The semi-structured interview assessed each sub-
ject’s CDI knowledge and traced workflow from patient
presentation with CDI symptoms through CDI 1.)
Identification, 2.) Diagnosis, 3.) Treatment, and 4.)
Prevention. Interview questions were structured to re-
veal facilitators and barriers to these CDI workflow
steps and opportunities to improve CDI treatment. The
interview guide included optional probes to use when
appropriate to gather additional information. When
participants revealed a lack of CDI knowledge from the
preliminary questions, the interview was then modified
to contain general questions about diarrhoea manage-
ment. As a qualitative study, the interviewer could use
information gathered from prior interviews to direct
future interview discussions and build on emerging
concepts. For example, asking for further detail and im-
plications on processes mentioned with open-ended
questions.
Participants
Providers working in three public secondary (district)
level hospitals in the Western Cape, Cape Town Metro-
pole, South Africa were invited to participate in this
study. The three participating hospitals, averaging 265
inpatient beds overall, were previously selected to be
included in a CDI quality improvement intervention.
Our study aimed to interview, at minimum, 15
providers among five provider types including front-
line nurses, nurse managers, pharmacists, junior physi-
cians (registrars and medical officers), and senior
physicians (consultants and department administrators).
Semi-structured interviews and focus groups occurred
August–November 2016.
Study investigators included healthcare providers from
the US and South Africa with local hospital affiliations.
The interviewers, a study investigator and a visiting US
pharmacy resident, recruited front-line healthcare pro-
viders with convenience and snowball sampling, and re-
cruited senior providers with purposive sampling. There
were no participant exclusion criteria. Interviews were
conducted as focus group discussions if preferred by
participants. Participants were provided an informed
consent document approved by the ethics committee
prior to the interview and could decline participation at
any time. Interviews were conducted by the interviewer
in consultation rooms and offices. All interviews were
conducted in English by one of the two interviewers
with questions from a semi-structured interview guide
and probing techniques by the interviewer. Interviews
continued until thematic saturation was observed re-
garding barriers and facilitators for CDI treatment and
management. The University of the Western Cape Re-
search Ethics Committee granted approval for this quali-
tative study.
Data analysis
Interview audio recordings were transcribed verbatim
and checked for accuracy. Data analysis included coding
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to factors determined a priori (including key workflow
steps: 1) Identification, 2) Diagnosis, 3) Treatment, and
4) Prevention) as well as inductive coding to emerging
themes [7]. Two individuals from a team of three coders
(LL, TE, and KP) conducted each coding phase. Paired
coding with two coders per phase was performed to
minimize bias. Coding schema was created to reconcile
local medical terminology. Discrepancies in coding were
resolved by consensus. Kappa scores were calculated to
assess coding agreement at a mid-point and at the con-
clusion of coding. While we had initially planned to map
results with the SEIPS framework, CDI management
knowledge was significantly lower than expected and in-
sufficient to frame the results in terms of tools, people,
tasks, the internal environment, and the organization.
Alternatively, we mapped coded themes to the workflow
structure identified from the interviews.
After identifying large discrepancies in health care pro-
vider knowledge regarding CDI during the interview
process, a scoring system was developed to categorize
participants’ CDI knowledge from their interview re-
sponses (Table 1). The intent of the assessment was to
quantify the unexpected differences. With the knowledge
assessment, one knowledge point was possible from each
of the following seven CDI-related components: signs
and symptoms (e.g. diarrhoea), characteristics of bacteria
(e.g. microbiology, virulence mechanism, disruption of
normal flora, opportunistic), hand hygiene (e.g. soap and
water needed to clean hands, not just alcohol), treatment
(e.g. metronidazole, oral vancomycin, fecal transplant,
contraindication with loperamide), contact precautions/
isolation (contagious), risk factors (e.g. healthcare
exposure, antibiotic use, immunocompromised by medi-
cation or illness [cancer, HIV status, CD4 count < 200]
proton pump inhibitor use), and diagnosis (e.g. stool
sample and testing methods, polymerase chain reac-
tion[PCR]/toxin detection). The following responses did
not receive a point allocation: 1) only stating ‘bacterial
infection’ for characteristics of bacteria, 2) stating a
non-specific sign and symptoms of infection or illness
without stating diarrhoea, 3) stating rehydration (elec-
trolytes) without specific antibiotic treatment name.
Total knowledge score from each individual interview
was further classified into four categories: ‘no know-
ledge’ (0–1 point), ‘limited knowledge’ (2–3 points),
‘moderate knowledge’ (4–5 points), and ‘advanced know-
ledge’ (6–7 points). Each CDI knowledge category was
also scored across all interviewees. Researchers con-
ducted subgroup analysis of knowledge level based on
occupation and performed analysis of individual CDI as-
sessment knowledge categories by participant and occu-
pation. The two focus group interviews were excluded
from the knowledge assessment analysis due to potential
knowledge score overestimation. However, dialogue
from the group interviews was included in the qualita-
tive analysis. All analyses were conducted using NVIVO
software (Version 11, QSR International).
Results
A total of 26 semi-structured interviews were conducted
with healthcare providers (11 nurses, 4 pharmacists, 11
physicians) of various rankings (Table 2). In addition, two
focus groups were conducted; one with seven nurses and
the second with three pharmacists, resulting in 36 study
participants (Table 2). Kappa scores indicated high interco-
der agreement (midpoint kappa = 0.71, final kappa 0.63).
The median overall CDI knowledge score from the 26 indi-
vidual interviews was 3 [interquartile range 0.25, 4.75].
Subgroup median knowledge scores and an analysis of re-
sponders’ knowledge of each category are presented in
Table 3. Inductive themes were coded for processes re-
quired for CDI workflow and organizational culture (beliefs
and attitudes) regarding change (i.e. the ease of positive
change at the organization or ‘change culture’) in order to
inform future interventions. Healthcare provider responsi-
bility and accountability for components of CDI manage-
ment emerged as an organizational culture theme from the
interviews. Thematic saturation of barriers and facilitators
to CDI management was reached across the health care
provider types (i.e. no additional themes emerged after it-
erative analysis of 26 interview and two focus group tran-
scripts) [8]. CDI workflow steps are presented along with
corresponding knowledge scores, barriers, and facilitators,
(Section I: Workflow) and followed by organizational cul-
ture themes (Section II: Organizational Culture).
Table 1 Clostridium difficile knowledge assessment
Criteria for Clostridium difficile knowledge Points
Signs and symptoms (diarrhoea) 1
States characteristics of bacteria (any mention of:
microbiology, virulence mechanism, disruption of
normal flora, opportunistic)
1
Soap and water needed to clean hands, not just alcohol 1
Treatment options (any mention of: metronidazole, oral
vancomycin, fecal transplant, contraindication with
loperamide)
1
Contact isolation needed (or contagious) 1
Risk factors (immunocompromised, antibiotic use,
proton pump inhibitors)
1
Diagnosis (stool sample, testing methods [PCR/toxins]) 1
Total points =
No knowledge = 0–1a
Limited knowledge = 2–3
Moderate knowledge = 4–5
Advanced knowledge = 6–7
aPoint allocation of 1 is considered no knowledge because there are multiple
diseases associated with any one of the criteria, unless person states
characteristics of bacteria
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Section I: Workflow
Figure 1 presents workflow depicted from interview re-
sults, along with facilitators and barriers to CDI manage-
ment summarized in the context of the CDI workflow,
including the previously identified steps of CDI identifica-
tion, diagnosis, treatment, and prevention. When CDI is
suspected, a stool sample is sent to an offsite laboratory
for C. difficile identification by PCR. Following CDI diag-
nosis, treatment and infection prevention and control
measures are initiated. Processes were consistent between
healthcare providers with knowledge of the workflow step.
Identification and healthcare provider knowledge
CDI identification requires knowledge of the bacteria, risk
factors and clinical suspicion when patients present with
CDI signs and symptoms. A major barrier to identification
is low CDI knowledge. Ten interviews (6 nurses, 4 phar-
macists) scored as ‘no CDI knowledge’ (Table 3). One par-
ticipant candidly revealed the lack of CDI knowledge.
“It’s actually the first time that I hear about it, to be
honest” - Pharmacist
CDI signs and symptoms were most commonly known
by healthcare providers (n = 16, 61.5%). Thirteen (50%)
participants could not describe CDI risk factors that
could prompt clinical inquiry for CDI; this knowledge
gap creates a potential barrier for prompt identification.
Two physicians reported extensive experience with CDI
in the United Kingdom. A recurrent theme from the in-
terviews among providers was that identification for
Table 3 Clostridium difficile infection (CDI) knowledge scores overall, by healthcare provider, and each CDI knowledge category
CDI knowledge sorted by healthcare provider
Occupation Overall
Nurse (n = 11) Physician (n = 11) Pharmacist (n = 4) All participants (n = 26)
Median Score (0–7), [1st, 3rd interquartile] 1 [0, 2.5] 5 [4, 6] 0.5 [0, 1] 3 [0.25, 4.75]
Knowledge Classification, n (%)
No 6 (54.5) 0 (0.0) 4 (100.0) 10 (38.5)
Limited 4 (36.4) 0 (0.0) 0 (0.0) 4 (15.4)
Moderate 0 (0.0) 6 (54.5) 0 (0.0) 6 (23.1)
Advanced 1 (100.0) 5 (45.5) 0 (0.0) 6 (23.1)
Knowledge assessed in each CDI knowledge category
Components of CDI knowledge assessment, n (%)
1. Identification 1.1 Characteristics of bacteria 2 (18.2) 4 (36.4) 0 (0.0) 6 (23.1)
1.2 Risk factors 3 (27.3) 10 (90.9) 0 (0.0) 13 (50.0)
1.3 Signs and symptoms 3 (27.3) 11 (100.0) 2 (50.0) 16 (61.5)
2. Diagnosis 2.1 Diagnosis 1 (9.1) 10 (90.9) 0 (0.0) 11 (42.3)
3. Treatment 3.1 Treatment options 1 (9.1) 7 (63.6) 0 (0.0) 8 (30.8)
4. Prevention 4.1 Hand washing needed 4 (36.4) 7 (63.6) 0 (0.0) 11 (42.3)
4.2 Need for contact isolation 4 (36.4) 8 (72.7) 0 (0.0) 12 (46.2)
Table 2 Occupations and stated titles of healthcare providers
interviewed
Healthcare Provider Occupation Participants Interviews
Nurse
Operational managers or Assistant manager 4 4
Registered nurse or unspecified nurse 4 4
Infection Prevention and Control Nurse 2 2
Nurse Training Clinical Program Coordinator 1 1
Ward Nurses Focus Group Interview 7 1
Subtotal: 18 12
Pharmacist
Pharmacist 4 4
Pharmacist Focus Group Interview 3 1
Subtotal: 7 5
Physician
Head of Department 2 2
Consultant 1 1
Unspecified physician 1 1
Registrar 1 1
Medical officer 5 5
Intern 1 1
Subtotal: 11 11
Total (N) 36 28
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HIV and TB was prioritized over CDI. Physicians who
have worked in the United Kingdom (U.K.) elaborated
that the sense of urgency in South Africa for CDI was
different than their previous experience due to compet-
ing attention of other prevalent disease.
“When I was in the UK [United Kingdom] years ago…
[when] the manager mentioned C. diff the staff would
jump up and down and get incredibly panicky… we
just don’t have that sense of urgency here… if you
mention to someone in any hospital, they will go
‘Okay, what is that?’ [in cavalier tone]... however, if
you tell them there is a patient with a potential XDR-
TB [Extensively drug-resistant TB], then they may
jump up and down. So the whole thing with C. diff it’s
a reality… …a lot of people just think it’s a disease
with the elderly, but we have a lot of immunocom-
promised patients…” - Physician
At one hospital, CDI awareness in senior staff only in-
creased after an outbreak in the hospital. Awareness was
lower for rotating junior staff who did not experience
the outbreak.
“In terms of my junior staff, I think [CDI] ranks quite
low. I think it’s got to do with the way we’ve become
Fig. 1 Clostridium difficile infection (CDI) identification, diagnosis, treatment, and prevention workflow: facilitators and barriers
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aware last year. We’ve had more cases making us
aware that it’s highly infectious.” - Physician
While some providers conjectured CDI to be a na-
tional problem, others did not, and no providers were
aware of CDI magnitude in South Africa. Facilitating
CDI identification were the senior providers with higher
CDI knowledge. At one of the hospitals, an ASP was ref-
erenced as attributing to low incidence.
Diagnosis
After identification, to inform diagnosis, a stool sample
from the patient is tested at a laboratory for C. difficile.
While all hospitals in our study had laboratory testing
available to conduct a C. difficile PCR test, testing oc-
curred offsite as there was not capacity for the PCR test
at the onsite laboratory. In order to test for C. difficile,
physicians must indicate the test on a standardized la-
boratory form. Perception of time to result varied widely
and was attributed to delays in initiating treatment. Add-
itional barriers identified included staff difficulties
obtaining stool samples due to staff shortages and
non-standardized collection of laboratory samples. La-
boratory test costs were occasionally cited as reasons to
not test for C. difficile. Eleven interview participants de-
scribed CDI diagnosis (42.3%, Table 3).
“Most of the time they are not tested, because they
come from the emergency, and because our emergency
is so busy, then the patient is pushed up to the ward.
So then only when the patient is in the ward, and then
we are actually reporting the [diarrhoea] to them [post
call]. And then report that the patient is having
diarrhoea; then that’s the only time that they collect a
stool specimen, and then after some, a couple of days,
they get the results: the patient is positive. See... It
could be about a week.” - Nurse Focus Group
Other attributes identified in delaying the time to diag-
nosis include waiting for a physician to suggest the C.
difficile test or until ward rounds to order it. To find re-
sults, physicians must proactively login to the database—
usually from their personal mobile phones, as computer
stations are not easily available. One of three hospitals
uses a mobile messaging application for direct messaging
from the microbiology laboratory to physicians with the
goal of reducing the result notification time.
“I think the one resource that we’ve shown very well is
the communication system. I think we chose the
cheapest one we could find which is WhatsApp and
that does make a difference in terms of managing your
patients and getting a quicker diagnosis. The thing
about WhatsApp is if a patient had a positive result,
it would take the doctor another 2 days to figure it out
that an infection exists. We actually have an alert
system that works.” - Physician
After observing the test result, the physician informs
the nursing staff if the patient has a CDI. The IPC
nurses are also informed of results and may, in turn, in-
form the medical team. However, there is not a timely
and consistent pathway for this notification, especially
during post-call hours. The IPC nurse sends physicians a
report including positive C. difficile test results on a
monthly basis.
Treatment
Antibiotic treatment options for antibiotic-associated
diarrhoea included in South African treatment guide-
lines at the time of the interviews were oral metronida-
zole initially and oral vancomycin for diarrhoea not
responsive to metronidazole; vancomycin must be oral
to reach the infection. Of note, the interviews were con-
ducted prior to the revised IDSA CDI guidelines in 2018
[3]. Eight (30.8%) respondents mentioned CDI treatment
options, including treatment with metronidazole and
vancomycin, though the importance of antibiotic treat-
ment administered orally was reported inconsistently
and occasionally inaccurately.
A few providers also discussed the clinical use of
metronidazole compared to vancomycin, including pa-
tients’ illness severity.
“So patients who don’t respond to metronidazole
would definitely be candidates for vancomycin or a
metronidazole allergy.” - Physician
Communication barriers were attributed to delays in
treatment and included factors such as results being fi-
nalized while the physician was post call and drug order
errors needing clarification.
Healthcare providers’ high familiarity with metronida-
zole and its availability on the hospital floor as ward
stock facilitated its use for CDI treatment. To order
vancomycin and other antibiotics on the Essential Medi-
cine List for Hospital Level Adults, providers needed to
complete a pharmacy-approved motivation form that fa-
cilitates appropriate antibiotic use. Participants reported
a time gap between ordering, sending the medication
chart to the pharmacy, having the medication delivered
to the ward, and administrating it to the patients. Some
orders might be written up and not sent to the phar-
macy. For stat orders, nurses may retrieve orders from
the pharmacy. The pharmacies were closed during eve-
nings and weekends. An emergency stock of inventory is
kept in the emergency center. If the needed drug is un-
available, an on-call pharmacist is called-in to prepare it.
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Occasionally medication was not administered and in-
correctly documented as unavailable while drug was
available in the emergency stock. Other reported barriers
to patients receiving medications as ordered included: il-
legible handwriting, medication orders not including
which ward an order came from, and physicians writing
brand names when nurses only know the generic name.
Additionally, sometimes a medication was given and not
recorded; other times the patients missed doses because
they were not present.
“The problem with this is ...that sometimes the results
come back, the doctor is post call. Yes, and then he
will only get the feedback the next day when he is
actually coming to check on his patients. So that is the
delay to start”- Nurse Focus Group
Prevention: Contact precautions, hand hygiene, isolation,
environmental cleaning
Contact precautions CDI prevention procedures include
contact precautions (e.g. gown, gloves) to reduce the risk
of C. difficile spreading to other patients. Twelve (46.2%)
participants reported the need for strict contact precau-
tions when CDI was suspected or diagnosed. Supplies and
procedures for IPC (included posters displaying orders
for contact precautions) were usually available but not
always utilised. Supplies (including gowns, gloves,
masks, and hand sanitizer) were available in close
proximity to a patient once contact precautions were
ordered. Staff education and timely notification of
need for infection control were the most common
barriers to IPC measures. Pressure from patient bed
shortages can lead to patients being placed near each
other. Contact precautions with the first suspicion of
CDI was described at one of the hospitals.
“...any patient with diarrhoea is placed with contact
precaution; until we know if they have been exposed to
any antibiotics, we put them as high risk.” - Physician
At the three hospitals, the ward nurse in charge will
enforce contact precautions with the nurses and the at-
tending/consulting physicians will enforce junior physi-
cians’ contact precautions. The IPC team also enforces
IPC practices. Both physicians and nurses inform pa-
tients about contact precautions; patients are told to in-
form their family members. While senior physicians
reported informing patients of the need for IPC in the
CDI setting, nurses considered themselves more ap-
proachable than the physicians and took a primary role
in communicating with patients. One junior physician
admitted his/her peers’ shortfalling.
“I think that from all of it, that is where the biggest
failing comes in—that we often don’t tell patients
enough of the stuff. So, I would like to think that
once it’s done there is a proper [communication]
about the patient having things that can be
transmitted, with words that they can understand
and the importance of them not going around and
touching lots of things and letting them know the
reasons for gloving up and putting on gowns and
stuff for their own peace of mind…It’s apathy from
the medical staff we forget to do these things...” -
Physician
Hand hygiene Facilitators and barriers to hand hygiene
were related to the treatment of patients with CDI and
additional infections. Hand hygiene practices for pa-
tients with CDI should include hand washing with soap
and water to remove C. difficile spores that are not
killed by alcohol hand sanitizers. Supplies, including
paper towels, soap, and hand sanitizer, were frequently
available but not always utilised. Some stated that insuf-
ficient supplies were a barrier; others said that supplies
were always available. Eleven (42.3%) participants ac-
knowledged the importance of washing hands with soap
and water when treating patients with CDI (Table 3).
“...have to use soap and water, we take [the] de-germ
[alcohol based hand sanitizer] away from bedside so
they are forced to use soap and water.” - Physician
Some perceptions regarding this important hand hy-
giene practice were inaccurate.
“I would not say a normal hand soap is better for C.
diff, I would say something alcohol based.” - Physician
Staffing shortages and high workload were described
as reasons for inconsistent hand hygiene practices.
“Can I tell you, all over the basins is that sign
[WHO’s “5 Moments of Hand Hygiene”]… but we
don’t practice it...We don’t follow five moments of
Hand Hygiene. We follow it when we go home... You
can’t afford to take that 5 min.” – Nurse Focus
Group
Participants described hand hygiene events (e.g. ultravi-
olent light, blue soap) in their hospitals that encouraged
effective hand hygiene. Many stated that overcrowding
and lack of facilities (e.g. one sink per ward) hindered
hand hygiene as well as: the high ratio of patients to
nurses, education limitations, and sometimes-empty al-
cohol and/or soap dispensers.
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Isolation Infrastructure limitations were a major barrier
to IPC, often preventing CDI patients from allocation to
an isolation room. Isolation room availability ranged
from two to four rooms. Isolation rooms were specific-
ally prioritized for multidrug resistant tuberculosis
(MDR-TB) patients, who may occupy the room for a
month. CDI is viewed as a lower priority for isolation
rooms.
“The fact that we have got a lot of
immunocompromised patients in terms of our HIV
rates and TB rates, a lot of our patients are at risk
due to the use of antibiotics. In the UK we used to see
a lot of elderly patients, but here you have got a
different spectrum of patients, so C. diff is a huge
risk… I think everyone focuses on MDR and very few
people actually focus on C. diff … C. diff is not
something that is high on the radar.” - Physician
Challenges for IPC included patient education regard-
ing IPC, especially patients leaving isolation, walking
around the hospital, and using shared bathrooms.
“The big problem that we have in our wards is a lack
of isolation facilities. For an entire hospital, we’ve got
only four isolation rooms [that] do not include
isolation bathrooms. So a C. diff patient would have to
use the same toilet as other patients.” - Physician
Both nurses and physicians described speaking to pa-
tients and their family members about isolation. An ele-
vated desire from patients to understand their condition
was expressed when patients were moved to an isolation
room.
“Sometimes you’ll find the patient doesn’t know what
is going on, but when you move them into an isolation
room then they want to know why.” - Nurse
Environmental cleaning The ward managers inform
cleaning staff verbally about room cleaning needs. Under
supervision, the cleaners complete a written checklist for
the bathrooms and patient rooms. Cleaning is some-
times rushed due to high bed demand, and the staff
nurses will help.
“It’s just that we are busy so the beds are always in
demand so sometimes there is no opportunity for
cleaning because everything is rush, rush, rush, rush.
When the patient is waiting on discharge, others are
waiting for that bed so we don’t have the opportunity
to do the spring cleaning of the unit. We aren’t always
able to do it in a calm environment.” – Nurse
Section II: Organizational Culture
Themes related to organizational culture (beliefs and
attitudes) and how leadership and administration re-
spond to new ideas, specifically ‘change culture’, were an-
alyzed in order to inform future interventions. Through
this coding an additional organizational culture theme
emerged related to healthcare provider responsibility
and accountability.
Change culture: how leadership and administration respond
to new ideas
The majority of respondents described leadership as be-
ing supportive of new ideas. Some respondents did not
feel leadership was supportive of bottom-up ideas;
others believed that ideas with evidence of positive im-
pact would be supported. A few respondents noted a
barrier to change related more to nursing staff and jun-
ior physician turnover than to administrative support.
Progressive change is difficult when the same education
concepts are repeated with rotating healthcare providers;
institutional memory regarding CDI and CDI manage-
ment was lost.
“Implementing change and practical change are very
different, so we are able to change our practice so we
can make lots of suggestions... but the difficulty comes
in that our staff [is a] rotating staff.” - Physician
A nurse new to a leadership position anticipated facing
challenges in changing long-standing practices.
“The people above me, the specialist physicians or
consultants, are quite open to change. If you can show
clearly that an idea is going to work, the department
is open to change and improving things. As you get
higher up the leadership chain, it becomes more
difficult to introduce change. I do find that on the face
of it, the managers seem to be okay and accepting and
are happy to listen.” - Physician
Responsibility and accountability
While the interviewees described achievements of and
challenges for patients and healthcare providers following
IPC precautions, low adherence emerged as a compelling
theme—sometimes in the context of IPC in general and
for the treatment of TB, particularly when participants
had limited CDI knowledge. Perception of the threats
from infectious diseases and IPC prioritization also appear
to be barriers to adherence when supplies are available.
Accountability structures are not in place to properly en-
courage providers to remain knowledgeable about guide-
lines nor enforce IPC precautions.
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“It seems we have many awareness days… we had
spike last year, 2 years ago… we have had quite a few
staff members contracted tuberculosis… people only get
aware if their buddy gets it… It makes it real.” -
Physician
“Just to get the doctors to wear gloves—that for me is
another thing where I can just say… like, ‘Why are you
not wearing gloves?’ or, just tell them ‘Your patient has
TB. Can you put on your mask please?’ ...together with
the hand washing, and at the end of the day, it is part
of the IPC principles to have full personal protection
equipment available in the unit, but there’s hand
sanitizers, soap, and water, available in the unit, so no
one has an excuse.” - Physician
Informal structures for peer accountability were dis-
cussed as a helpful strategy from two interviews. First,
accountability for hand hygiene occurred on the ASP
ward round at one hospital. Second, an Operational
Manager in the Operating Room (Theater) described
nursing and cleaning staff who speak up about needs
and follow cleaning expectations.
“The cleaning staff and the nursing staff is quite well
informed as to what is supposed to happen, because
sometimes they can tell you. ‘Sister, this was not done
yet; You can’t really put your patient here’… Those are
the people that I work with... that I come across, that
will tell me. Doesn’t matter if you are the cleaner, you
can tell me, ‘Sister, it’s not ready yet.’ You understand.
It’s that relationship that we have [of a]
multidisciplinary team, to do what is expected of us.”
– Nurse
Discussion
Principal findings
This is the first qualitative study of CDI in Sub-Saharan Af-
rica, and the results provide novel insight into CDI treat-
ment and workflow in a limited resource setting. The
context of CDI in Africa is especially important to consider
given the high HIV and tuberculosis prevalence and high
risk of C. difficile associated mortality in this population.
This study reveals significant barriers and facilitators to
CDI treatment in public district (secondary) level South
African hospitals. Major barriers included knowledge gaps
in CDI management, especially regarding awareness of the
infection, transmission, treatment, and IPC practices
among health care providers. Physician CDI knowledge
was higher than nurse and pharmacist knowledge. The re-
sults reveal opportunities for healthcare provider education
related to CDI. Our study affirms that healthcare providers
have an awareness of evidence-based IPC precautions but
barriers to following them include perceptions of priority
and time availability.
Implications: perceptions and knowledge
Based on quantitative results from the overall CDI
knowledge assessment, participants had limited CDI
knowledge. Gaps in CDI knowledge may delay clinical
suspicion and all workflow steps in CDI identification,
diagnosis, treatment and prevention. While physicians
scored higher, some physicians were less confident re-
garding when to order the C. difficile test resulting in
delayed diagnosis. Physicians with high CDI knowledge
noted an urgency surrounding CDI not observed in jun-
ior physicians and other healthcare providers.. This, to-
gether with a high risk of mortality in patients with
positive C. difficile test results, underscores an urgent
need for education and intervention tailored to relevant
aspects of healthcare providers’ job responsibilities.
Overall, participants scored well in areas of identifying
CDI risk factors, signs, and symptoms. However, im-
provement is needed in terms of educating healthcare
professionals in South Africa about other aspects of
CDI. In the occupation subgroup analysis, nurses and
pharmacists appear to be less knowledgeable about CDI
characteristics, with response rates of 50% or less in all
the knowledge assessment categories. The identified
areas for potential development relevant to nurses and
pharmacists are: CDI patients’ need for contact isolation,
the importance of hand washing instead of using alcohol
gel in preventing the spread of CDI, and CDI treatment
options. Nurses can also be educated to suspect CDI
when monitoring bowel movements.
This study reveals a more complicated process for
obtaining and administering vancomycin compared to
metronidazole that may be hindering healthcare providers’
use of vancomycin. In an epidemiology, treatment, and
outcomes study in the same setting, vancomycin was
rarely ordered (2%) as initial CDI treatment [4]. One strat-
egy is to incorporate treatment options for CDI into
pharmacist education and teach pharmacists what to look
for on physician-submitted motivation forms. Pharmacist
education about treatment options is especially important
considering the role pharmacists have in the approval
process for vancomycin use. The healthcare team should
be educated on the clinical use of vancomycin for CDI
with an emphasis on timely preparation and delivery.
How results relate to other studies
Our study affirms current literature’s described need for
improved CDI identification in settings with extensive
CDI experience. Despite a history of substantial CDI out-
breaks in Europe, a study identified persistent underdiag-
noses of CDI when all diarrhoea samples were tested at
482 hospitals across 20 European countries; 23% of C.
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difficile positive results were not identified at the local
hospital. Authors attributed the underdiagnoses to a lack
of clinical suspicion and suboptimal laboratory diagnostic
methods [9]. Meanwhile, in the US, a regulatory climate
that reduces hospital reimbursement for patients who de-
velop hospital-acquired infections is driving efforts to re-
fine testing protocols to avoid C. difficile over testing and
inappropriate diagnosis [10]. These studies emphasize the
importance of appropriate testing for diagnosis.
A global review of CDI guidelines found antimicrobial
stewardship (ASPs) to be universally recognized as an
essential evidence-based component of CDI IPC [5].
Continued development of interdisciplinary ASPs in lim-
ited resource settings is necessary to facilitate effective
CDI management and IPC measures.
One barrier to hand hygiene identified in this study
was the perception that there is insufficient time avail-
able for thorough hand cleaning. Indeed, in a study con-
ducted in the US about healthcare providers’ compliance
with IPC practices for patients with CDI, full compliance
was very low and time-consuming with a mean time for
full compliance greater than 5 min for patients in single
isolation rooms [11]. Patient care workload continues to
be a barrier to full compliance with CDI contact precau-
tions in high resource settings [12]. Therefore, improv-
ing full compliance of IPC practices in limited resource
settings will require both a workload adjustment to allow
more time per patient and education on the importance
of CDI-related IPC practices.
Significant challenges for the implementation of IPC
programs and practices exist in low and limited resource
settings, including infrastructural constraints with a lim-
ited number of isolation rooms and variable staff compli-
ance with hand hygiene practices. A similar qualitative
study in India found perceived workload and nursing staff
turnover to be barriers to infection control [13]. This re-
lates to our study’s previously referenced finding that per-
ceived workload hindered infection control practices,
especially regarding hand hygiene. Our respondents re-
ported high turnover of both nursing staff and junior phy-
sicians as barriers to implementing change. The secondary
hospitals included in our study did not have an IPC team
as developed as the one in the tertiary hospital in India.
The study in India also found participants reporting the
availability of IPC supplies but experiencing challenges
with compliance, while an international study of health-
care settings representing 30 countries identified inad-
equate supplies as a barrier to infection control of
multidrug resistant organisms in some high and middle
income countries [13, 14].
Limitations
As a qualitative study, the results are not generalizable
to a larger population but may be transferable to similar
settings. Visiting researchers’ presence conducting the
interviews may have affected responses; stated practices
are not necessarily the reality of practice. While all inter-
views were conducted in English, English was a second
language for some participants. This may have limited
the respondents’ understanding of some questions and
ability to articulate responses. Furthermore, we may have
underestimated facilitators to CDI management in an at-
tempt to identify improvement opportunities. Our ana-
lysis was not a systematic audit of workflow and
practices, and some inaccuracies may exist. To mitigate
bias, multiple researchers of the study team reviewed the
results. Finally, as we developed the knowledge assess-
ment after the interviews were completed, the assess-
ment is not yet validated and results are limited. Our
knowledge assessment measured breadth of CDI know-
ledge and not depth. For example, some providers gave
detailed explanations for some of the knowledge compo-
nents, such as advantages of different testing protocols,
yet these explanations were still only assigned one point
for that component.
Conclusions
Our analysis provides a detailed description of the facilita-
tors and barriers to CDI workflow, including the need for
increased healthcare provider knowledge of CDI manage-
ment. Interventions should increase CDI knowledge and
utilization of the available systems and supplies by ad-
dressing the identified barriers and championing the iden-
tified facilitators. Increasing CDI knowledge alone is
unlikely to be effective without addressing the need to cre-
ate a sense of urgency around CDI and appropriate IPC
practices. The results provide context for technical inter-
vention and implementation strategies in low-resource
public healthcare settings. This study serves as a baseline
and supplements quantitative CDI patient data from on-
going CDI research including provider education and a
clinical intervention to improve CDI quality of care in
South Africa. The results of this workflow and provider
knowledge analysis identify areas of need and are useful to
design interventions to improve the quality of care for
CDI patients in this population and similar limited re-
source settings.
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